{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:19:46Z","timestamp":1794745186515,"version":"4.9.1"},"reference-count":163,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>The current guidelines are an updated version of the Indian Psychiatric Society\u2019s Clinical Practice Guidelines (CPG) for Obsessive-Compulsive Disorder (OCD), published in 2017. The CPG aims to provide an evidence-based framework for the assessment and management of OCD across different age groups and those with comorbidities. We conducted a systematic literature search since the publication of the previous guidelines in 2017. We provide the level of evidence and strength of recommendation for the treatment strategies in different phases of illness. A comprehensive evaluation of OCD symptoms, insight, comorbidities, and relevant treatment history is essential for formulating a detailed management plan. Selective serotonin reuptake inhibitors and cognitive behavior therapy remain the first-line treatment for OCD. The choice of treatment strategy is based on various factors, including illness severity, psychiatric and other medical comorbidities, previous treatment trials, affordability, accessibility, hypersensitivity, side-effect profile, and patients\u2019 preferences. Current evidence on different forms and modes of psychotherapy delivery is provided. We discuss the level of evidence and strength of recommendations for pharmacological and psychological augmentation strategies as well as for neuromodulatory and neurosurgical interventions. The challenges and strategies for management of OCD in those with comorbid psychiatric and physical illnesses are discussed. Evaluation and evidence-based management strategies in the pediatric and geriatric populations are also discussed. The guidelines provide an evidence-based framework that can be adapted by the practitioner to suit the distinctive needs of individual patients and the clinical setting.<\/jats:p>","DOI":"10.4103\/indianjpsychiatry_1259_25","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:00:32Z","timestamp":1769508032000},"page":"44-67","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Clinical practice guidelines for obsessive-compulsive disorder: 2025 update"],"prefix":"10.4103","volume":"68","author":[{"given":"Shyam Sundar","family":"Arumugham","sequence":"first","affiliation":[{"name":"Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janardhanan C.","family":"Narayanaswamy","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, MHDAS, Barwon Health and Institute for Mental and Physical Health and Clinical Translation (IMPACT), Deakin University, Geelong, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Balachander","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eesha","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TS","family":"Jaisoorya","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Chaitanya","family":"Reddy","sequence":"additional","affiliation":[{"name":"Telemedicine Centre, NIMHANS Digital Academy, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleem M.","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Era\u2019s Lucknow Medical College and Hospital, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash","family":"Desouza","sequence":"additional","affiliation":[{"name":"Consultant Psychiatrist and Founder Trustee, Desousa Foundation, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parag S.","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Surat Municipal Institute of Medical Education and Research, Surat, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YC Janardhan","family":"Reddy","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"R1-20260420","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/mp.2008.94","article-title":"The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication","volume":"15","author":"Ruscio","year":"2010","journal-title":"Mol Psychiatry"},{"key":"R2-20260420","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/475027a","article-title":"Grand challenges in global mental health","volume":"475","author":"Collins","year":"2011","journal-title":"Nature"},{"key":"R3-20260420","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.4088\/JCP.13r08849","article-title":"Long-term outcome of obsessive-compulsive disorder in adults: A meta-analysis","volume":"75","author":"Sharma","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2014.07.009","article-title":"Factors associated with non-treatment or delayed treatment seeking in OCD sufferers: A review of the literature","volume":"220","author":"Garc\u00eda-Soriano","year":"2014","journal-title":"Psychiatry Res"},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1176\/appi.ajp.2008.08020320","article-title":"Meta-analysis of the symptom structure of obsessive-compulsive disorder","volume":"165","author":"Bloch","year":"2008","journal-title":"Am J Psychiatry"},{"key":"R8-20260420","doi-asserted-by":"crossref","first-page":"703701","DOI":"10.3389\/fpsyt.2021.703701","article-title":"Comorbidities in obsessive-compulsive disorder across the lifespan: A systematic review and meta-analysis","volume":"12","author":"Sharma","year":"2021","journal-title":"Front Psychiatry"},{"key":"R9-20260420","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.comppsych.2017.04.002","article-title":"Comorbidity, age of onset and suicidality in obsessive-compulsive disorder (OCD): An international collaboration","volume":"76","author":"Brakoulias","year":"2017","journal-title":"Compr Psychiatry"},{"key":"R10-20260420","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/acps.12250","article-title":"Diagnostic validity of comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review","volume":"129","author":"Amerio","year":"2014","journal-title":"Acta Psychiatr Scand"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00406-006-0658-2","article-title":"Comorbidity of anxiety disorders in patients with remitted bipolar disorder","volume":"256","author":"Zutshi","year":"2006","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jad.2014.12.019","article-title":"Comorbid obsessive compulsive disorder in patients with bipolar-I disorder","volume":"174","author":"Shashidhara","year":"2015","journal-title":"J Affect Disord"},{"key":"R13-20260420","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1440-1819.2011.02247.x","article-title":"Obsessive-compulsive disorder with and without bipolar disorder","volume":"65","author":"Mahasuar","year":"2011","journal-title":"Psychiatry Clin Neurosci"},{"issue":"Suppl 1","key":"R14-20260420","first-page":"S140","article-title":"Obsessive-compulsive disorder comorbid with schizophrenia and bipolar disorder","volume":"61","author":"Sharma","year":"2019","journal-title":"Indian J Psychiatry"},{"issue":"Suppl 20","key":"R15-20260420","first-page":"22","article-title":"The mini-international neuropsychiatric interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R17-20260420","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1073191116638410","article-title":"Psychometric properties of a structured diagnostic interview for DSM-5 anxiety, mood, and obsessive-compulsive and related disorders","volume":"25","author":"Tolin","year":"2018","journal-title":"Assessment"},{"key":"R18-20260420","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown obsessive compulsive scale. I. Development, use, and reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"R19-20260420","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/00004583-199706000-00023","article-title":"Children\u2019s Yale-Brown obsessive compulsive scale: Reliability and validity","volume":"36","author":"Scahill","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R20-20260420","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/sj.mp.4001798","article-title":"The dimensional Yale-Brown obsessive-compulsive scale (DY-BOCS): An instrument for assessing obsessive-compulsive symptom dimensions","volume":"11","author":"Rosario-Campos","year":"2006","journal-title":"Mol Psychiatry"},{"key":"R21-20260420","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1037\/a0018260","article-title":"Assessment of obsessive-compulsive symptom dimensions: Development and evaluation of the dimensional obsessive-compulsive scale","volume":"22","author":"Abramowitz","year":"2010","journal-title":"Psychol Assess"},{"key":"R22-20260420","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1176\/ajp.155.1.102","article-title":"The brown assessment of beliefs scale: Reliability and validity","volume":"155","author":"Eisen","year":"1998","journal-title":"Am J Psychiatry"},{"key":"R23-20260420","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0005-7967(98)00191-0","article-title":"The overvalued ideas scale: Development, reliability and validity in obsessive-compulsive disorder","volume":"37","author":"Neziroglu","year":"1999","journal-title":"Behav Res Ther"},{"key":"R24-20260420","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0005-7967(02)00099-2","article-title":"Psychometric validation of the Obsessive Beliefs Questionnaire and the Interpretation of Intrusions Inventory: Part I","volume":"41","year":"2003","journal-title":"Behav Res Ther"},{"key":"R25-20260420","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/00005053-199910000-00008","article-title":"Family accommodation of obsessive-compulsive symptoms: Instrument development and assessment of family behavior","volume":"187","author":"Calvocoressi","year":"1999","journal-title":"J Nerv Ment Dis"},{"issue":"Suppl 1","key":"R26-20260420","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.4103\/0019-5545.196976","article-title":"Clinical practice guidelines for obsessive-compulsive disorder","volume":"59","author":"Janardhan Reddy","year":"2017","journal-title":"Indian J Psychiatry"},{"key":"R27-20260420","first-page":"431","article-title":"Brazilian research consortium on obsessive-compulsive spectrum disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part II: Cognitive-behavioral therapy","volume":"45","author":"de Mathis","year":"2023","journal-title":"Braz J Psychiatry"},{"key":"R28-20260420","first-page":"146","article-title":"Brazilian research consortium on obsessive-compulsive spectrum disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part I: Pharmacological treatment","volume":"45","author":"de Oliveira","year":"2023","journal-title":"Braz J Psychiatry"},{"key":"R29-20260420","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/15622975.2022.2086296","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders-Version 3. Part II: OCD and PTSD","volume":"24","author":"Bandelow","year":"2023","journal-title":"World J Biol Psychiatry"},{"issue":"7 Suppl","key":"R30-20260420","first-page":"5","article-title":"Practice guideline for the treatment of patients with obsessive-compulsive disorder","volume":"164","author":"Koran","year":"2007","journal-title":"Am J Psychiatry"},{"key":"R32-20260420","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/07067437241245384","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: R\u00e9seau canadien pour les traitements de l\u2019humeur et de l\u2019anxi\u00e9t\u00e9 (CANMAT) 2023 : Mise \u00e0 jour des lignes directrices cliniques pour la prise en charge du trouble d\u00e9pressif majeur chez les adultes","volume":"69","author":"Lam","year":"2024","journal-title":"Can J Psychiatry"},{"key":"R33-20260420","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S2215-0366(16)30069-4","article-title":"Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: A systematic review and network meta-analysis","volume":"3","author":"Skapinakis","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"R34-20260420","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0004867412461958","article-title":"Pharmacotherapy of obsessive-compulsive disorder: Evidence-based treatment and beyond","volume":"47","author":"Fineberg","year":"2013","journal-title":"Aust N Z J Psychiatry"},{"key":"R35-20260420","doi-asserted-by":"crossref","first-page":"e300951","DOI":"10.1136\/bmjment-2023-300951","article-title":"Influence of study characteristics, methodological rigour and publication bias on efficacy of pharmacotherapy in obsessive-compulsive disorder: A systematic review and meta-analysis of randomised, placebo-controlled trials","volume":"27","author":"Cohen","year":"2024","journal-title":"BMJ Ment Health"},{"key":"R36-20260420","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.4088\/JCP.v63n1108","article-title":"Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: A preliminary single-blind, 12-week, controlled study","volume":"63","author":"Albert","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R37-20260420","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/01.jcp.0000095342.32154.54","article-title":"A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder","volume":"23","author":"Denys","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"R38-20260420","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1586\/14737175.2014.874287","article-title":"Commonly asked questions in the treatment of obsessive-compulsive disorder","volume":"14","author":"Arumugham","year":"2014","journal-title":"Expert Rev Neurother"},{"key":"R39-20260420","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/mp.2009.50","article-title":"Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder","volume":"15","author":"Bloch","year":"2010","journal-title":"Mol Psychiatry"},{"key":"R40-20260420","doi-asserted-by":"crossref","first-page":"e605","DOI":"10.4088\/JCP.14r09758","article-title":"Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: A meta-analysis","volume":"77","author":"Issari","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"R41-20260420","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/JCP.0000000000000989","article-title":"Effectiveness of venlafaxine in selective serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: Experience from a specialty clinic in India","volume":"39","author":"Balachander","year":"2019","journal-title":"J Clin Psychopharmacol"},{"key":"R42-20260420","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/00004714-200110000-00016","article-title":"Mirtazapine treatment of obsessive-compulsive disorder","volume":"21","author":"Koran","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"R43-20260420","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4088\/JCP.v66n0415","article-title":"Mirtazapine for obsessive-compulsive disorder: An open trial followed by double-blind discontinuation","volume":"66","author":"Koran","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R44-20260420","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/wps.20299","article-title":"Towards an international expert consensus for defining treatment response, remission, recovery and relapse in obsessive-compulsive disorder","volume":"15","author":"Mataix-Cols","year":"2016","journal-title":"World Psychiatry"},{"key":"R45-20260420","doi-asserted-by":"crossref","first-page":"pyv047","DOI":"10.1093\/ijnp\/pyv047","article-title":"Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: An update meta-analysis of double-blind, randomized, placebo-controlled trials","volume":"18","author":"Dold","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"R46-20260420","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/acps.13568","article-title":"Pharmacological augmentation of serotonin reuptake inhibitors in patients with obsessive-compulsive disorder: A network meta-analysis","volume":"148","author":"Maiti","year":"2023","journal-title":"Acta Psychiatr Scand"},{"key":"R47-20260420","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/archpsyc.1994.03950040046006","article-title":"Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics","volume":"51","author":"McDougle","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"R48-20260420","doi-asserted-by":"crossref","first-page":"494","DOI":"10.29271\/jcpsp.2025.04.494","article-title":"Effectiveness and safety of memantine add-on treatment for refractory obsessive-compulsive disorder: A meta-analysis","volume":"35","author":"Zhang","year":"2025","journal-title":"J Coll Physicians Surg Pak"},{"key":"R49-20260420","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1017\/S1092852919001500","article-title":"Pregabalin augmentation for resistant obsessive-compulsive disorder: A double-blind placebo-controlled clinical trial","volume":"25","author":"Mowla","year":"2020","journal-title":"CNS Spectr"},{"key":"R50-20260420","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1038\/npp.2013.150","article-title":"Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: Proof-of-concept","volume":"38","author":"Rodriguez","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"R51-20260420","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/02698811241301215","article-title":"Ketamine for treatment-resistant obsessive-compulsive disorder: Double-blind active-controlled crossover study","volume":"39","author":"Beaglehole","year":"2025","journal-title":"J Psychopharmacol"},{"key":"R52-20260420","doi-asserted-by":"crossref","first-page":"102183","DOI":"10.1016\/j.ajp.2020.102183","article-title":"Clinical utility of repeated intravenous ketamine treatment for resistant obsessive-compulsive disorder","volume":"52","author":"Sharma","year":"2020","journal-title":"Asian J Psychiatr"},{"key":"R53-20260420","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/pcn.12803","article-title":"Amantadine as adjuvant therapy in the treatment of moderate to severe obsessive-compulsive disorder: A double-blind randomized trial with placebo control","volume":"73","author":"Naderi","year":"2019","journal-title":"Psychiatry Clin Neurosci"},{"key":"R54-20260420","first-page":"32","article-title":"L-carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double-blind study","author":"Arabzadeh","year":"2017","journal-title":"Hum Psychopharmacol"},{"key":"R55-20260420","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/pcn.12430","article-title":"Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial","volume":"70","author":"Esalatmanesh","year":"2016","journal-title":"Psychiatry Clin Neurosci"},{"key":"R56-20260420","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/pcn.13565","article-title":"L-theanine combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial","volume":"77","author":"Nematizadeh","year":"2023","journal-title":"Psychiatry Clin Neurosci"},{"key":"R57-20260420","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jpsychires.2023.10.029","article-title":"Serotonin 3 receptor antagonists for obsessive-compulsive disorder: A systematic review and pairwise meta-analysis","volume":"167","author":"Hamanaka","year":"2023","journal-title":"J Psychiatr Res"},{"key":"R58-20260420","doi-asserted-by":"crossref","first-page":"20837","DOI":"10.1038\/s41598-023-47931-x","article-title":"Efficacy and safety of 5-hydroxytryptamine-3 (5-HT3) receptor antagonists in augmentation with selective serotonin reuptake inhibitors (SSRIs) in the treatment of moderate to severe obsessive-compulsive disorder: A systematic review and meta-analysis of randomized clinical trials","volume":"13","author":"Eissazade","year":"2023","journal-title":"Sci Rep"},{"key":"R59-20260420","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4088\/JCP.v65n0106","article-title":"A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder","volume":"65","author":"Denys","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R60-20260420","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.janxdis.2011.05.007","article-title":"Cognitive behavior therapy in medication non-responders with obsessive-compulsive disorder: A prospective 1-year follow-up study","volume":"25","author":"Anand","year":"2011","journal-title":"J Anxiety Disord"},{"key":"R61-20260420","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1176\/appi.ajp.2007.07091440","article-title":"A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder","volume":"165","author":"Simpson","year":"2008","journal-title":"Am J Psychiatry"},{"key":"R62-20260420","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jamapsychiatry.2013.1932","article-title":"Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: A randomized clinical trial","volume":"70","author":"Simpson","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"R63-20260420","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1586\/ern.12.160","article-title":"Augmentation strategies in obsessive-compulsive disorder","volume":"13","author":"Arumugham","year":"2013","journal-title":"Expert Rev Neurother"},{"key":"R64-20260420","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12888-014-0317-5","article-title":"Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: A systematic review and meta-analysis","volume":"14","author":"Veale","year":"2014","journal-title":"BMC Psychiatry"},{"key":"R65-20260420","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pnpbp.2018.12.009","article-title":"Augmentation agents to serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder: A network meta-analysis","volume":"90","author":"Zhou","year":"2019","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R66-20260420","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1186\/s12888-025-06856-7","article-title":"Memantine augmentation of escitalopram in treatment of executive function among patients with obsessive-compulsive disorder (OCD): A double-blind placebo-controlled randomized clinical trial","volume":"25","author":"Mirzazadeh","year":"2025","journal-title":"BMC Psychiatry"},{"key":"R67-20260420","doi-asserted-by":"crossref","first-page":"19f13163","DOI":"10.4088\/JCP.19f13163","article-title":"Augmentation with memantine in obsessive-compulsive disorder","volume":"80","author":"Andrade","year":"2019","journal-title":"J Clin Psychiatry"},{"key":"R68-20260420","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/15622975.2022.2082525","article-title":"Treatment strategies for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: A network meta-analysis of randomised controlled trials","volume":"24","author":"Suhas","year":"2023","journal-title":"World J Biol Psychiatry"},{"key":"R69-20260420","doi-asserted-by":"crossref","first-page":"1421150","DOI":"10.3389\/fpsyt.2024.1421150","article-title":"The safety and efficacy of N-acetylcysteine as an augmentation in the treatment of obsessive-compulsive disorder in adults: A systematic review and meta-analysis of randomized clinical trials","volume":"15","author":"Eghdami","year":"2024","journal-title":"Front Psychiatry"},{"key":"R70-20260420","doi-asserted-by":"crossref","first-page":"716","DOI":"10.4088\/JCP.09m05266gre","article-title":"Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder","volume":"72","author":"Berlin","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"R71-20260420","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1017\/S1092852912000065","article-title":"Topiramate augmentation in resistant OCD: A double-blind placebo-controlled clinical trial","volume":"15","author":"Mowla","year":"2010","journal-title":"CNS Spectr"},{"key":"R72-20260420","first-page":"976","article-title":"Topiramate augmentation in refractory obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial","volume":"19","author":"Afshar","year":"2014","journal-title":"J Res Med Sci"},{"key":"R73-20260420","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/HRP.0000000000000330","article-title":"Ketamine in the treatment of obsessive-compulsive disorder: A systematic review","volume":"30","author":"Bandeira","year":"2022","journal-title":"Harv Rev Psychiatry"},{"key":"R74-20260420","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/npr2.12364","article-title":"Effects of riluzole on psychiatric disorders with anxiety or fear as primary symptoms: A systematic review","volume":"43","author":"Kawashima","year":"2023","journal-title":"Neuropsychopharmacol Rep"},{"key":"R75-20260420","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/0269881108099423","article-title":"Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: A randomized, open-label trial","volume":"24","author":"Diniz","year":"2010","journal-title":"J Psychopharmacol"},{"key":"R76-20260420","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/JCP.0b013e3182367aee","article-title":"A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder","volume":"31","author":"Diniz","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"R77-20260420","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/YIC.0000000000000415","article-title":"Is mirtazapine augmentation effective for patients with obsessive-compulsive disorder who failed to respond to sertraline monotherapy? A placebo-controlled, double-blind, clinical trial","volume":"38","author":"Mowla","year":"2023","journal-title":"Int Clin Psychopharmacol"},{"key":"R78-20260420","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.4088\/JCP.v65n1015","article-title":"Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: A pilot study","volume":"65","author":"Pallanti","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R79-20260420","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4088\/JCP.v67n0103","article-title":"High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: A multicenter double-blind trial","volume":"67","author":"Ninan","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R80-20260420","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/YIC.0b013e3282f0f0c5","article-title":"High-dose escitalopram for the treatment of obsessive-compulsive disorder","volume":"23","author":"Rabinowitz","year":"2008","journal-title":"Int Clin Psychopharmacol"},{"key":"R81-20260420","doi-asserted-by":"crossref","first-page":"949","DOI":"10.4088\/JCP.14r09129","article-title":"Electroconvulsive therapy for obsessive-compulsive disorder: A systematic review","volume":"76","author":"Fontenelle","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"R82-20260420","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1038\/s41380-022-01524-8","article-title":"Efficacy of neurostimulation across mental disorders: Systematic review and meta-analysis of 208 randomized controlled trials","volume":"27","author":"Hyde","year":"2022","journal-title":"Mol Psychiatry"},{"key":"R83-20260420","first-page":"1145","article-title":"A Meta-analysis of Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder","volume":"8","author":"Steuber","year":"2023","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"R84-20260420","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/07067437221121112","article-title":"Efficacy of repetitive transcranial magnetic stimulation on comorbid anxiety and depression symptoms in obsessive-compulsive disorder: A meta-analysis of randomized sham-controlled trials","volume":"68","author":"Thatikonda","year":"2023","journal-title":"Can J Psychiatry"},{"key":"R85-20260420","doi-asserted-by":"crossref","first-page":"103962","DOI":"10.1016\/j.ajp.2024.103962","article-title":"Comparative efficacy of repetitive transcranial magnetic stimulation protocols for obsessive-compulsive disorder: A network meta-analysis","volume":"94","author":"Vinod","year":"2024","journal-title":"Asian J Psychiatr"},{"key":"R86-20260420","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/acps.13809","article-title":"The Efficacy and acceptability of non-invasive brain stimulation interventions for obsessive-compulsive disorder management: A network meta-analysis based on 24 stimulation methods","volume":"152","author":"Tseng","year":"2025","journal-title":"Acta Psychiatr Scand"},{"key":"R87-20260420","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jad.2022.01.048","article-title":"Repetitive transcranial magnetic stimulation for obsessive-compulsive disorder: A systematic review and pairwise\/network meta-analysis","volume":"302","author":"Fitzsimmons","year":"2022","journal-title":"J Affect Disord"},{"key":"R88-20260420","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_496_22","article-title":"Clinical practice guidelines for the use of transcranial direct current stimulation in psychiatry","volume":"65","author":"Sreeraj","year":"2023","journal-title":"Indian J Psychiatry"},{"key":"R89-20260420","doi-asserted-by":"crossref","first-page":"106171","DOI":"10.1016\/j.neubiorev.2025.106171","article-title":"Efficacy and safety of transcranial direct current stimulation (tDCS) in patients with obsessive-compulsive disorder (OCD): A systematic review and meta-analysis of randomized controlled trials","volume":"173","author":"Moshfeghinia","year":"2025","journal-title":"Neurosci Biobehav Rev"},{"key":"R90-20260420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13651501.2025.2466498","article-title":"Transcranial direct current stimulation in patients with obsessive-compulsive disorder: A meta-analysis of randomised controlled trials","volume":"29","author":"Yan","year":"2025","journal-title":"Int J Psychiatry Clin Pract"},{"key":"R91-20260420","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41398-024-02736-y","article-title":"Targeting the prefrontal-supplementary motor network in obsessive-compulsive disorder with intensified electrical stimulation in two dosages: A randomized, controlled trial","volume":"14","author":"Alizadehgoradel","year":"2024","journal-title":"Transl Psychiatry"},{"key":"R92-20260420","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1017\/S1092852925000173","article-title":"A single-blind, randomized controlled trial of transcranial direct current stimulation in adults with obsessive-compulsive disorder as early augmentation","volume":"30","author":"Kumar","year":"2025","journal-title":"CNS Spectr"},{"key":"R93-20260420","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/s41386-020-00928-w","article-title":"Efficacy and safety of transcranial direct current stimulation as an add-on treatment for obsessive-compulsive disorder: A randomized, sham-controlled trial","volume":"46","author":"Silva","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"R94-20260420","doi-asserted-by":"crossref","first-page":"1338594","DOI":"10.3389\/fpsyt.2024.1338594","article-title":"Treating refractory obsessive compulsive disorder with cathodal transcranial direct current stimulation over the supplementary motor area: A large multisite randomized sham-controlled double-blind study","volume":"15","author":"Harika-Germaneau","year":"2024","journal-title":"Front Psychiatry"},{"key":"R95-20260420","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.eurpsy.2019.08.011","article-title":"Transcranial direct current stimulation in patients with obsessive compulsive disorder: A randomized controlled trial","volume":"62","author":"Bation","year":"2019","journal-title":"Eur Psychiatry"},{"key":"R96-20260420","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/13554794.2021.1936073","article-title":"The effect of transcranial direct current stimulation (tDCS) on cerebellum in reduction of the symptoms of obsessive-compulsive disorder","volume":"28","author":"Akbari","year":"2022","journal-title":"Neurocase"},{"key":"R97-20260420","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.brs.2019.02.005","article-title":"Efficacy of pre-supplementary motor area transcranial direct current stimulation for treatment resistant obsessive compulsive disorder: A randomized, double blinded, sham controlled trial","volume":"12","author":"Gowda","year":"2019","journal-title":"Brain Stimul"},{"key":"R98-20260420","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/jamapsychiatry.2014.1193","article-title":"Gamma ventral capsulotomy for obsessive-compulsive disorder: A randomized clinical trial","volume":"71","author":"Lopes","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"R99-20260420","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3171\/2010.5.JNS091277","article-title":"Stereotactic lesions for the treatment of psychiatric disorders","volume":"113","author":"Leiphart","year":"2010","journal-title":"J Neurosurg"},{"key":"R100-20260420","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3171\/2015.1.JNS14681","article-title":"Dorsal anterior cingulotomy and anterior capsulotomy for severe, refractory obsessive-compulsive disorder: A systematic review of observational studies","volume":"124","author":"Brown","year":"2016","journal-title":"J Neurosurg"},{"key":"R101-20260420","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/acps.13276","article-title":"Deep brain stimulation versus ablative surgery for treatment-refractory obsessive-compulsive disorder: A meta-analysis","volume":"143","author":"Hageman","year":"2021","journal-title":"Acta Psychiatr Scand"},{"key":"R102-20260420","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1503\/jpn.190079","article-title":"Effectiveness and safety of neuroablation for severe and treatment-resistant obsessive-compulsive disorder: A systematic review and meta-analysis","volume":"45","author":"Lai","year":"2020","journal-title":"J Psychiatry Neurosci"},{"key":"R103-20260420","doi-asserted-by":"crossref","first-page":"104354","DOI":"10.1016\/j.ajp.2024.104354","article-title":"Deep brain stimulation - A primer for psychiatrists","volume":"104","author":"Sharma","year":"2025","journal-title":"Asian J Psychiatr"},{"key":"R104-20260420","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1038\/s41380-025-03092-z","article-title":"Deep brain stimulation for obsessive-compulsive-disorder: A systematic review and meta-analysis of individual participant outcome data from sham-controlled trials","volume":"30","author":"Cohen","year":"2025","journal-title":"Mol Psychiatry"},{"key":"R105-20260420","doi-asserted-by":"crossref","first-page":"19r12821","DOI":"10.4088\/JCP.19r12821","article-title":"Efficacy, effect on mood symptoms, and safety of deep brain stimulation in refractory obsessive-compulsive disorder: A systematic review and meta-analysis","volume":"81","author":"Martinho","year":"2020","journal-title":"J Clin Psychiatry"},{"key":"R106-20260420","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3389\/fnins.2018.00998","article-title":"Deep brain stimulation for obsessive compulsive disorder: Evolution of surgical stimulation target parallels changing model of dysfunctional brain circuits","volume":"12","author":"Karas","year":"2018","journal-title":"Front Neurosci"},{"key":"R107-20260420","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2021-328738","article-title":"Efficacy of deep brain stimulation for treatment-resistant obsessive-compulsive disorder: Systematic review and meta-analysis","author":"Gadot","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R108-20260420","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jad.2020.12.082","article-title":"A randomized controlled trial of mindfulness-based cognitive therapy vs stress management training for obsessive-compulsive disorder","volume":"282","author":"Mathur","year":"2021","journal-title":"J Affect Disord"},{"key":"R109-20260420","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00406-018-0957-4","article-title":"Mindfulness-based cognitive therapy (MBCT) in patients with obsessive-compulsive disorder (OCD) and residual symptoms after cognitive behavioral therapy (CBT): A randomized controlled trial","volume":"269","author":"K\u00fclz","year":"2019","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R110-20260420","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/0145445520982977","article-title":"A preliminary examination of acceptance and commitment therapy versus exposure and response prevention for patients with obsessive-compulsive disorder on an optimal dose of SSRIs: A randomized controlled trial in Iran","volume":"46","author":"Zemestani","year":"2022","journal-title":"Behav Modif"},{"key":"R111-20260420","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1037\/a0020508","article-title":"A randomized clinical trial of acceptance and commitment therapy versus progressive relaxation training for obsessive-compulsive disorder","volume":"78","author":"Twohig","year":"2010","journal-title":"J Consult Clin Psychol"},{"key":"R112-20260420","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jad.2017.08.014","article-title":"A randomized controlled study of brief family-based intervention in obsessive compulsive disorder","volume":"225","author":"Baruah","year":"2018","journal-title":"J Affect Disord"},{"key":"R113-20260420","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.psychres.2005.10.012","article-title":"Cognitive retraining for organizational impairment in obsessive-compulsive disorder","volume":"144","author":"Buhlmann","year":"2006","journal-title":"Psychiatry Res"},{"key":"R114-20260420","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1192\/bjp.133.3.200","article-title":"Obsessive thoughts: The problem of therapy","volume":"133","author":"Stern","year":"1978","journal-title":"Br J Psychiatry"},{"key":"R115-20260420","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000318296","article-title":"No effect of adding brief dynamic therapy to pharmacotherapy in the treatment of obsessive-compulsive disorder with concurrent major depression","volume":"79","author":"Maina","year":"2010","journal-title":"Psychother Psychosom"},{"key":"R116-20260420","doi-asserted-by":"crossref","first-page":"152223","DOI":"10.1016\/j.comppsych.2021.152223","article-title":"Cognitive behavioural therapy with exposure and response prevention in the treatment of obsessive-compulsive disorder: A systematic review and meta-analysis of randomised controlled trials","volume":"106","author":"Reid","year":"2021","journal-title":"Compr Psychiatry"},{"key":"R117-20260420","doi-asserted-by":"crossref","first-page":"104170","DOI":"10.1016\/j.brat.2022.104170","article-title":"Cognitive behavior therapy for obsessive-compulsive disorder in routine clinical care: A systematic review and meta-analysis","volume":"159","author":"\u00d6st","year":"2022","journal-title":"Behav Res Ther"},{"key":"R118-20260420","doi-asserted-by":"crossref","first-page":"152305","DOI":"10.1016\/j.comppsych.2022.152305","article-title":"Optimizing first line treatments for adults with OCD","volume":"115","author":"Nezgovorova","year":"2022","journal-title":"Compr Psychiatry"},{"key":"R119-20260420","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.brat.2014.10.007","article-title":"A pilot randomized controlled trial of videoconference-assisted treatment for obsessive-compulsive disorder","volume":"63","author":"Vogel","year":"2014","journal-title":"Behav Res Ther"},{"key":"R120-20260420","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jaac.2014.09.012","article-title":"Telephone cognitive-behavioral therapy for adolescents with obsessive-compulsive disorder: A randomized controlled non-inferiority trial","volume":"53","author":"Turner","year":"2014","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R121-20260420","doi-asserted-by":"crossref","first-page":"e221967","DOI":"10.1001\/jamanetworkopen.2022.1967","article-title":"Effect of internet-based vs face-to-face cognitive behavioral therapy for adults with obsessive-compulsive disorder: A randomized clinical trial","volume":"5","author":"Lundstr\u00f6m","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R122-20260420","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jad.2022.11.007","article-title":"Efficacy of remotely-delivered cognitive behavioural therapy for obsessive-compulsive disorder: An updated meta-analysis of randomised controlled trials","volume":"322","author":"Salazar de Pablo","year":"2023","journal-title":"J Affect Disord"},{"key":"R123-20260420","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpsychires.2023.10.025","article-title":"Comparison of internet-based and face-to-face cognitive behavioral therapy for obsessive-compulsive disorder: A systematic review and network meta-analysis","volume":"168","author":"Zhang","year":"2023","journal-title":"J Psychiatr Res"},{"key":"R124-20260420","doi-asserted-by":"crossref","first-page":"e2989","DOI":"10.1002\/cpp.2989","article-title":"Internet-based cognitive behavioural treatments for obsessive-compulsive disorder: A systematic review and meta-analysis","volume":"31","author":"Polak","year":"2024","journal-title":"Clin Psychol Psychother"},{"key":"R125-20260420","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/0706743720927830","article-title":"Long-term outcomes of intensive inpatient care for severe, resistant obsessive-compulsive disorder","volume":"65","author":"Balachander","year":"2020","journal-title":"Can J Psychiatry"},{"key":"R126-20260420","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jpsychires.2024.06.007","article-title":"Effects of inpatient, residential, and day-patient treatment on obsessive-compulsive symptoms in persons with obsessive-compulsive disorder: A systematic review and meta-analysis","volume":"176","author":"Zisler","year":"2024","journal-title":"J Psychiatr Res"},{"key":"R127-20260420","doi-asserted-by":"crossref","first-page":"113303","DOI":"10.1016\/j.psychres.2020.113303","article-title":"A prospective study of intensive in-patient treatment for obsessive-compulsive disorder","volume":"291","author":"Nanjundaswamy","year":"2020","journal-title":"Psychiatry Res"},{"key":"R128-20260420","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jocrd.2016.05.001","article-title":"Efficacy of group psychotherapy for obsessive-compulsive disorder: A meta-analysis of randomized controlled trials","volume":"10","author":"Schwartze","year":"2016","journal-title":"J Obsessive-Compulsive Relat Disord"},{"key":"R129-20260420","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.3389\/fpsyg.2019.02500","article-title":"A randomized controlled trial of concentrated ERP, self-help and waiting list for obsessive- compulsive disorder: The Bergen 4-day treatment","volume":"10","author":"Launes","year":"2019","journal-title":"Front Psychol"},{"key":"R130-20260420","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12888-018-1887-4","article-title":"Successfully treating 90 patients with obsessive compulsive disorder in eight days: The Bergen 4-day treatment","volume":"18","author":"Kvale","year":"2018","journal-title":"BMC Psychiatry"},{"key":"R131-20260420","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/16506073.2018.1478447","article-title":"The Bergen 4-day treatment for OCD: Four years follow-up of concentrated ERP in a clinical mental health setting","volume":"48","author":"Hansen","year":"2019","journal-title":"Cogn Behav Ther"},{"key":"R132-20260420","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/PRA.0000000000000377","article-title":"Mindfulness-based cognitive therapy for obsessive-compulsive disorder: A pilot study","volume":"25","author":"Didonna","year":"2019","journal-title":"J Psychiatr Pract"},{"key":"R133-20260420","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1471-244X-12-185","article-title":"Mindfulness-based cognitive therapy in obsessive-compulsive disorder-A qualitative study on patients\u2019 experiences","volume":"12","author":"Hertenstein","year":"2012","journal-title":"BMC Psychiatry"},{"key":"R134-20260420","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.psc.2025.02.004","article-title":"Acceptance and commitment therapy for obsessive-compulsive disorder","volume":"48","author":"Lee","year":"2025","journal-title":"Psychiatr Clin North Am"},{"key":"R135-20260420","doi-asserted-by":"crossref","first-page":"100446","DOI":"10.1016\/j.jocrd.2019.100446","article-title":"Improving treatment outcome in obsessive-compulsive disorder: Does motivational interviewing boost efficacy?","volume":"22","author":"McCabe","year":"2019","journal-title":"J Obsessive-Compulsive Relat Disord"},{"key":"R136-20260420","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1002\/cpp.2120","article-title":"A randomized controlled trial comparing EMDR and CBT for obsessive-compulsive disorder","volume":"25","author":"Marsden","year":"2018","journal-title":"Clin Psychol Psychother"},{"key":"R137-20260420","doi-asserted-by":"crossref","first-page":"e0173660","DOI":"10.1371\/journal.pone.0173660","article-title":"D-cycloserine augmentation of behavior therapy for anxiety and obsessive-compulsive disorders: A meta-analysis","volume":"12","author":"B\u00fcrkner","year":"2017","journal-title":"PLoS One"},{"key":"R138-20260420","doi-asserted-by":"crossref","first-page":"973838","DOI":"10.3389\/fpsyt.2022.973838","article-title":"The effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: A systematic review and meta-analysis","volume":"13","author":"Mao","year":"2022","journal-title":"Front Psychiatry"},{"key":"R139-20260420","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jad.2021.08.146","article-title":"Comorbid depression and treatment of anxiety disorders, OCD, and PTSD: Diagnosis versus severity","volume":"295","author":"Klein Breteler","year":"2021","journal-title":"J Affect Disord"},{"key":"R140-20260420","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpsychires.2024.09.048","article-title":"Efficacy of pharmacological treatment in OCD comorbid with tic disorder: Systematic review and meta-analysis","volume":"180","author":"Jalenques","year":"2024","journal-title":"J Psychiatr Res"},{"key":"R141-20260420","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jad.2014.05.026","article-title":"Treatment of comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review","volume":"166","author":"Amerio","year":"2014","journal-title":"J Affect Disord"},{"key":"R142-20260420","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/PRA.0000000000000499","article-title":"Pharmacological treatment for comorbid bipolar disorder and obsessive-compulsive disorder in adults","volume":"26","author":"Netto","year":"2020","journal-title":"J Psychiatr Pract"},{"issue":"Suppl 1","key":"R143-20260420","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.4103\/psychiatry.IndianJPsychiatry_526_18","article-title":"The role of personality disorders in obsessive-compulsive disorder","volume":"61","author":"Thamby","year":"2019","journal-title":"Indian J Psychiatry"},{"key":"R144-20260420","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jad.2015.11.004","article-title":"Clinical management of perinatal anxiety disorders: A systematic review","volume":"190","author":"Marchesi","year":"2016","journal-title":"J Affect Disord"},{"key":"R145-20260420","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1017\/S0033291716003573","article-title":"A pilot randomized controlled trial of time-intensive cognitive-behaviour therapy for postpartum obsessive-compulsive disorder: Effects on maternal symptoms, mother-infant interactions and attachment","volume":"47","author":"Challacombe","year":"2017","journal-title":"Psychol Med"},{"key":"R146-20260420","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.clinthera.2007.05.003","article-title":"Paroxetine and congenital malformations: Meta-Analysis and consideration of potential confounding factors","volume":"29","author":"Bar-Oz","year":"2007","journal-title":"Clin Ther"},{"key":"R147-20260420","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1056\/NEJMoa067407","article-title":"First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects","volume":"356","author":"Louik","year":"2007","journal-title":"N Engl J Med"},{"key":"R148-20260420","doi-asserted-by":"crossref","first-page":"d8012","DOI":"10.1136\/bmj.d8012","article-title":"Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: Population based cohort study from the five Nordic countries","volume":"344","author":"Kieler","year":"2012","journal-title":"BMJ"},{"key":"R149-20260420","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/157340411794474784","article-title":"Antidepressant use during breastfeeding","volume":"7","author":"Berle","year":"2011","journal-title":"Curr Womens Health Rev"},{"key":"R150-20260420","doi-asserted-by":"crossref","first-page":"1414677","DOI":"10.3389\/fphar.2024.1414677","article-title":"Sertraline, citalopram and paroxetine in lactation: Passage into breastmilk and infant exposure","volume":"15","author":"Den Besten-Bertholee","year":"2024","journal-title":"Front Pharmacol"},{"key":"R151-20260420","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.psc.2006.02.012","article-title":"Obsessive-compulsive and spectrum disorders in children and adolescents","volume":"29","author":"Geller","year":"2006","journal-title":"Psychiatr Clin North Am"},{"key":"R152-20260420","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11920-019-1015-2","article-title":"Epidemiological and clinical gender differences in OCD","volume":"21","author":"Mathes","year":"2019","journal-title":"Curr Psychiatry Rep"},{"key":"R153-20260420","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaacop.2023.09.007","article-title":"Intensive cognitive-behavioral therapy telehealth for pediatric obsessive-compulsive disorder during the COVID-19 pandemic: Comparison with a matched sample treated in person","volume":"2","author":"Franklin","year":"2024","journal-title":"JAACAP Open"},{"key":"R154-20260420","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1007\/s10578-020-01066-6","article-title":"An evaluation of a new autism-adapted cognitive behaviour therapy manual for adolescents with obsessive-compulsive disorder","volume":"52","author":"Jassi","year":"2021","journal-title":"Child Psychiatry Hum Dev"},{"key":"R157-20260420","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1001\/jama.292.16.1969","article-title":"Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: The Pediatric OCD Treatment Study (POTS) randomized controlled trial","volume":"292","year":"2004","journal-title":"JAMA"},{"key":"R158-20260420","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/jcpp.13934","article-title":"Efficacy and acceptability of cognitive-behavioral therapy and serotonin reuptake inhibitors for pediatric obsessive-compulsive disorder: A network meta-analysis","volume":"65","author":"Cervin","year":"2024","journal-title":"J Child Psychol Psychiatry"},{"key":"R159-20260420","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s10567-019-00296-y","article-title":"Family-based psychological treatment for obsessive compulsive disorder in children and adolescents: A meta-analysis and systematic review","volume":"22","author":"McGrath","year":"2019","journal-title":"Clin Child Fam Psychol Rev"},{"key":"R160-20260420","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jaac.2016.07.768","article-title":"Systematic review and meta-analysis: early treatment responses of selective serotonin reuptake inhibitors and clomipramine in pediatric obsessive-compulsive disorder","volume":"55","author":"Varigonda","year":"2016","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R161-20260420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20430","article-title":"A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive-compulsive disorder in children\/adolescents and adults","volume":"20","author":"Skapinakis","year":"2016","journal-title":"Health Technol Assess"},{"key":"R162-20260420","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/cap.2023.0018","article-title":"What is the added benefit of combining cognitive behavioral therapy and selective serotonin reuptake inhibitors in youth with obsessive compulsive disorder? A Bayesian hierarchical modeling meta-analysis","volume":"33","author":"Mendez","year":"2023","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R163-20260420","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1016\/j.jaac.2023.09.365","article-title":"5.41 psychopharmacological augmentation strategies in pediatric OCD: A systematic review and pooled analysis","volume":"62","author":"Rajalakshmi","year":"2023","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R164-20260420","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s40272-024-00639-5","article-title":"Pediatric treatment-resistant obsessive compulsive disorder: Treatment options and challenges","volume":"26","author":"Younus","year":"2024","journal-title":"Paediatr Drugs"},{"key":"R165-20260420","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1186\/s12877-024-05440-0","article-title":"Prevalence of obsessive-compulsive disorder in the older person: A systematic review and meta-analysis","volume":"24","author":"Heydarikhayat","year":"2024","journal-title":"BMC Geriatr"},{"key":"R166-20260420","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.euroneuro.2017.10.007","article-title":"Exploring sociodemographic and clinical correlates of older adults with obsessive-compulsive disorder: A report from the International College of Obsessive-Compulsive Disorders (ICOCS)","volume":"28","author":"Benatti","year":"2018","journal-title":"Eur Neuropsychopharmacol"},{"key":"R167-20260420","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/PRA.0000000000000463","article-title":"Obsessive-compulsive disorder in older adults: A comprehensive literature review","volume":"26","author":"Jazi","year":"2020","journal-title":"J Psychiatr Pract"},{"key":"R169-20260420","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/070674370605100702","article-title":"The psychological treatment of obsessive-compulsive disorder","volume":"51","author":"Abramowitz","year":"2006","journal-title":"Can J Psychiatry"},{"key":"R170-20260420","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1077-7229(99)80019-4","article-title":"Cognitive behavioral treatment of older adults with obsessive-compulsive disorder","volume":"6","author":"Carmin","year":"1999","journal-title":"Cogn Behav Pract"}],"container-title":["Indian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/indianjpsychiatry_1259_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:28:02Z","timestamp":1786724882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/indianjpsychiatry_1259_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":163,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/indianjpsychiatry_1259_25","relation":{},"ISSN":["0019-5545","1998-3794"],"issn-type":[{"value":"0019-5545","type":"print"},{"value":"1998-3794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-11-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}